2m 2m 2m 2m 2m 2m 2m
Immuron Sp ADR (IMRN)
NASDAQ
$1.09$0.00 (0.00%)
Price as of Oct 02, 2026 7:31 PM EDT- $9.1MMarket Cap
- -49.30%1-Year Change
- BiotechnologyIndustry
Immuron Sp ADR (IMRN)
$1.09$0.00 (0.00%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7.7M +5.85% | 7.3M +48.63% | 4.9M +171.67% | 1.8M +135.85% | |
Cost of Revenue | N/A N/A | 2.5M +61.03% | 1.6M +216.02% | 495,558 +105.04% | |
Gross Profit | 7.7M +61.88% | 4.8M +42.80% | 3.3M +154.88% | 1.3M +150.07% | |
Sales and Marketing Expense | 497,048 -85.60% | 3.5M +70.10% | 2.0M +118.85% | 927,423 +122.65% | |
Research and Development Expense | N/A N/A | -3.6M -33.08% | -5.4M +107.38% | -2.6M +294.11% | |
Depreciation and Amortization Expense | 42,320 -14.83% | 49,688 +8.06% | 45,981 -5.51% | 48,662 +82.85% | |
Total Operating Expenses | N/A N/A | 4.5M -1.58% | 4.6M +7.93% | 4.2M +19.76% | |
Operating Profit | -3.9M -27.95% | -5.3M -7.87% | -5.8M +62.55% | -3.6M +24.36% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | 1.4M -58.59% | 3.4M +31.51% | 2.6M +170.59% | |
Income before Taxes | N/A N/A | -5.2M -24.81% | -6.9M +83.20% | -3.8M +32.66% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -5.2M -24.81% | -6.9M +83.20% | -3.8M +32.66% | |
Net Income from Continuing Operations Applicable to Common | N/A N/A | -5.2M -24.81% | -6.9M +83.20% | -3.8M +32.66% | |
Basic EPS and Net Income | -1.24 -45.13% | -2.26 -25.66% | -3.04 +83.13% | -1.66 +32.80% | |
Diluted EPS and Net Income | -1.24 -45.13% | -2.26 -25.66% | -3.04 +83.13% | -1.66 +32.80% | |
Basic Weighted Average Shares | 297.1M +28.65% | 230.9M +1.35% | 227.9M N/A | N/A N/A | |
Diluted Weighted Average Shares | 297.1M +28.65% | 230.9M +1.35% | 227.9M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.0M +218.59% | 2.8M -75.72% | 11.7M -32.07% | 17.2M -22.39% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 404,117 N/A | |
Cash and Cash Equivalents and Short-Term Investments | 9.0M +218.59% | 2.8M -75.72% | 11.7M -33.63% | 17.6M -20.56% | |
Total Current Assets | 13.0M +29.39% | 10.0M -31.99% | 14.7M -27.85% | 20.4M -13.78% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 9,325 -91.82% | 113,950 -26.17% | 154,347 -22.88% | 200,133 -11.73% | |
Total Long-Term Assets | 192,721 +68.14% | 114,616 -86.08% | 823,632 -47.83% | 1.6M +33.39% | |
Total Assets | 13.2M +29.83% | 10.1M -34.86% | 15.5M -29.28% | 22.0M -11.54% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.8M -9.19% | 2.0M -27.15% | 2.7M +21.62% | 2.2M +47.65% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 201,147 +112.68% | 94,577 -33.18% | 141,546 -7.00% | 152,207 -13.25% | |
Total Liabilities | 2.0M -3.60% | 2.1M -27.45% | 2.8M +19.79% | 2.4M +41.28% | |
Retained Earnings | -85.0M +3.07% | -82.4M +4.40% | -79.0M +9.59% | -72.1M +5.31% | |
Total Stockholders Equity | 11.2M +38.37% | 8.1M -36.51% | 12.7M -35.21% | 19.6M -15.36% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | -3.3M -46.88% | -6.1M +4.37% | -5.9M +126.58% | -2.6M -17.56% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 3.2M +211.73% | -2.9M -985.46% | 327,561 +112.50% | -2.6M -22,433.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.5M +3,141.68% | 199,747 +23,994.93% | 829 +101.86% | -44,667 +5.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 65.39% -3.92% | 68.06% -6.18% | 72.54% +6.03% | |
Operating Margin | -49.92% -31.94% | -73.34% -38.01% | -118.32% -40.17% | -197.75% -47.27% | |
Return on Assets | N/A N/A | -40.62% +9.91% | -36.96% +128.62% | -16.17% +47.01% | |
Return on Equity | N/A N/A | -50.21% +16.98% | -42.92% +142.53% | -17.70% +52.12% | |
Revenue Growth | 5.85% -87.96% | 48.63% -71.67% | 171.67% +26.37% | 135.85% -68.03% | |
Current Ratio | 7.26 +42.49% | 5.09 -6.65% | 5.46 -40.67% | 9.20 -41.61% | |
Cash Ratio | 5.05 +250.83% | 1.44 -66.67% | 4.32 -44.14% | 7.73 -47.44% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow